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ABSTRACT
There  is  virtually  no  evidence  for  the  effectiveness  of  interventions  to  promote  early 
presentation in breast cancer. We tested the efficacy of an intervention to equip older women 
with the knowledge, skills,  confidence and motivation to detect  symptoms and seek help 
promptly,  with the aim of  promoting early presentation with breast cancer symptoms. We 
randomised 867 women aged 67 to 70 attending for their final routine appointment on the UK 
NHS  Breast  Screening Programme to  receive:  a  scripted  ten-minute  interaction  with  a 
radiographer plus a booklet; a booklet alone; or usual care. The primary outcome was whether 
or not a woman was breast cancer aware based on knowledge of breast cancer symptoms 
and age-related risk; and reported breast checking. At one month, the intervention increased 
the proportion who were breast cancer aware compared with usual care (interaction arm: 
32.8% versus 4.1%; odds ratio 24.0, 95% confidence interval 7.7 to 73.7; booklet arm: 12.7% 
versus 4.1%; odds ratio 4.4, 95% confidence interval 1.6 to 12.0). At one year, the effects of 
the  interaction  plus  booklet,  and  the  booklet,  on  breast  cancer  awareness  were  largely 
sustained,  although  the  interaction  plus  booklet  remained  much  more  effective.  Future 
research will  evaluate  whether  the  intervention  promotes early  presentation  and reduces 
breast cancer mortality.
Keywords:  Aged, Awareness, Breast cancer, Breast neoplasms, Complex intervention, 
Delayed presentation, Health knowledge, Older women, One-to-one intervention, Randomized 
controlled trials
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INTRODUCTION
Women in the UK have poorer survival from breast cancer than many other Western European 
countries (Berrino et al, 2007), and differences in stage at diagnosis are largely responsible 
(Sant et al, 2003). Late stage at diagnosis is almost certainly due to late presentation by some 
women and delays in onward referral by some general practitioners. In the developed world, 
17-35% of women with breast cancer delay presenting for more than three months, and 9-20% 
delay more than six months (Westcombe et al, 1999; Arndt, 2002). We have found no high 
quality evidence of effectiveness of interventions to promote early presentation in breast, or 
any other cancer (Austoker et al, 2009 this supplement).
Risk factors for delay in presentation in breast cancer include older age, less education, and 
presenting with non-lump symptoms (Ramirez  et al,  1999). Older women have particularly 
poor knowledge of non-lump symptoms and the increase in breast cancer risk with age (Linsell 
et al, 2008; Grunfeld et al, 2002). About 20% of older women report that they never look at or 
feel their breasts (Linsell  et al, 2008). We hypothesise that breast cancer awareness, which 
might include breast cancer knowledge and the confidence, skills and motivation to detect 
symptoms and seek help appropriately, will reduce delays in presentation. 
We have built two versions of an intervention to promote early presentation of breast cancer in 
older women (Burgess  et al, 2008) aiming to equip them with breast cancer awareness: a 
booklet containing health-promoting messages and a scripted one-to-one interaction with a 
radiographer, supported by the booklet, both designed to be delivered during the final routine 
appointment  on the NHS Breast  Screening Programme, a  setting  giving  access  to  most 
English women aged 67 to 70. We targeted older women because they are at higher risk of 
breast cancer (Cancer Research UK, 2008), are more likely to delay presentation (Ramirez et  
al,  1999),  and  have  poorer  survival  (Office  for  National  Statistics,  2008).  The  positive 
predictive value of breast symptoms for breast cancer is higher in older than younger women 
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(Nichols et al, 1981). We based the design of the intervention on a theoretical framework for 
delayed  presentation  (Bish  et  al,  2005),  and  incorporated  techniques  to  maximise  the 
probability of behaviour change (Jepson, 2000; Wardle et al, 2003; Rollnick and Miller, 1995; 
Gollwitzer, 1999).
We have developed and evaluated the intervention in line with the Medical Research Council 
guidance on complex interventions (Medical Research Council, 2008). We have previously 
shown in a before-and-after exploratory trial  that the intervention increased breast cancer 
awareness in older women at six months (Burgess et al, 2009). We report here the one month 
and one year results of a randomised controlled trial of efficacy of the ten-minute interaction 
with a radiographer supported by a booklet versus the booklet alone versus usual care alone.
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MATERIALS AND METHODS
Participants and setting
Participants were a consecutive series of women aged 67 to 70 years attending final routine 
appointments on the NHS Breast Screening Programme. All women attending were eligible, 
unless  they  had a  significant  disorder  that  may have affected their  ability  to  consent  or 
participate, insufficient English or other language difficulties, or were going overseas during 
the subsequent six months. The women were recruited from seven breast screening units in 
London and Surrey.
Procedure
The screening units sent an invitation letter and information sheet to each potential participant 
two  weeks  before  her  appointment.  On  the  day  of  attendance,  a  trained  radiographer 
assessed whether  the  woman was eligible  and  obtained written  informed consent.  After 
completing a baseline questionnaire, women were randomly allocated to: usual care; booklet 
alone, or the ten-minute one-to-one interaction supported by the booklet, in addition to usual 
care.  We  sent  trial-specific  postal  questionnaires  at  one  and  twelve  months  post-
randomisation to collect outcome data. 
The intervention  
Usual care
The screening unit  receptionist informed each woman who had received her final  routine 
mammogram that she was no longer eligible for routine screening, advised her that she might 
continue to be screened every three years on request, and provided a card with contact details 
and a suggested date for contact.  
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The booklet
In addition to usual care, a radiographer gave a booklet to each woman who had received her 
final routine mammogram. The booklet conveyed key breast cancer awareness messages, 
including:
• A list of breast cancer symptoms;
• Age-related and absolute risk of developing breast cancer;
• How to detect a breast change;
• What to do on discovering a breast change;
• A strong direct recommendation to seek medical attention immediately on discovering 
a breast change, outlining the benefits of prompt help-seeking and suggestions for 
overcoming barriers such as embarrassment and fear;
• A direct recommendation to tell someone close in the event of discovering a breast 
change;
• An action plan to be completed by the woman about how she will be breast aware and 
what she will do on discovering a breast change;
• A  series  of  statements  describing  possible  positive  feelings  (relief,  reassurance, 
satisfaction) resulting from seeking help immediately with a breast change;
• A reminder that she might request further breast screening.
The interaction plus booklet
In addition to usual care, women received a scripted ten-minute one-to-one interaction with a 
radiographer  or  research  psychologist.  During  this,  the  radiographer/psychologist  verbally 
delivered all the messages in the booklet in a positive, collaborative and motivational style, 
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referred to the booklet throughout and gave it to the woman to take home. She also showed 
photographs of breast cancer signs and demonstrated and rehearsed breast checking using a 
silicone  breast.  The  radiographer  was  able  to  tailor  the  key  messages  by  checking  the 
woman’s understanding and answering any questions.
Quality assurance and quality control for the interaction plus booklet
After  receiving  training  and  being  assessed  as  competent,  five  radiographers  and  two 
research  psychologists delivered  the  interactions,  and  received  ongoing  performance 
feedback throughout. All interactions were video recorded and quality of each was assessed 
by an independent rater using a trial-specific quality checklist assessing content and style of 
delivery. Quality scores were standardised on a scale of 0 to 100. 
Outcomes
We measured outcomes at baseline and one, six and twelve months post-randomisation using 
a trial-specific questionnaire, an earlier version of which we have used in a survey (Linsell et 
al, 2008) and an exploratory trial (Burgess et al, 2009). We have demonstrated good test-re-
test reliability (Linsell, 2006) and sensitivity to change (Burgess et al, 2009).
The primary outcome was proportion of women achieving breast cancer awareness at one 
month, measured using a breast cancer awareness score. The score was a composite of 
responses to three questions from the questionnaire, relating to knowledge of  symptoms, 
knowledge of age-related risk and reported breast checking:
Knowledge of breast cancer symptoms: “Do you know any of the warning signs of breast  
cancer? If  yes,  please circle the signs you know below".  Women circled symptoms on a 
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scattered list of eleven symptoms (two lump and nine non-lump). To score one point, the 
woman had to identify at least five non-lump symptoms i.e. over half;
Knowledge of age-related risk: “In the next year who is most likely to get breast cancer?” 
Response categories: a 30 year old woman; a 50 year old woman; a 70 year old woman; a 
woman of any age. To score one point, the woman had to identify that a 70 year old was most 
likely to get breast cancer;
Breast checking:  “How often do you check your breasts?” Response categories: rarely or 
never; at least every six months; at least once a month; at least once a week. To score one 
point, the woman had to report checking her breasts at least once a month or at least once a 
week.
Each item was given equal weighting and contributed one point to the total score (range zero 
to three). To achieve breast cancer awareness, the woman had to respond correctly to all 
three items. 
We also collected data on relationship status, education and ethnicity at baseline. To estimate 
socioeconomic status, we used the  Index of Multiple Deprivation (Communities and Local 
Government, 2007) based on area of residence. This is a measure of deprivation at the small 
area level  (32,482 areas  in  England)  based on seven dimensions:  income,  employment, 
health, education, housing and services, living environment and crime. Every area in England 
is  ranked from 1 (most  deprived) to  32,482 (least  deprived);  median rank is  16,241.  We 
assigned each woman a rank of Index of Multiple Deprivation according to the rank of her area 
of residence. 
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Sample size
We estimated that 2% of women would be breast cancer aware at baseline (Burgess et al, 
2009) and that there would be a 12% difference between trial arms. Incorporating a design 
effect to take account of  clustering by centre and radiographer (Lee and Thompson, 2005) 
(assuming  an  intracluster  correlation  coefficient  of  0.08  and  14  participants  per  centre-
radiographer cluster) and allowing for 70% response, we required 238 women per arm (total 
714) with a significance level of 5% (two-sided) and power of 80%. 
Randomisation 
We randomised  women  individually  on  the  day  of  attendance,  with  equal  probability  of 
assignment to each arm. The trial statistician computer generated the allocation sequence 
using stratified block randomisation with centre and radiographer as stratification variables 
(block sizes of three, six and nine). To ensure concealment, assignments were enclosed in 
sequentially numbered, opaque, sealed envelopes and stored by the trial coordinator before 
randomisation. The radiographer recorded each participant's trial identification number on the 
envelope before opening it.
Statistical analysis
We analysed the data by intention to treat: all participants were analysed in the groups to 
which  they  were allocated.  We summarised continuous variables  using means,  standard 
deviations, medians and ranges, and categorical variables using counts and percentages. We 
used two-sided significance tests, taking p=0.05 as significant. All analyses were performed 
using Stata version 10.0. The primary comparative analyses for all outcomes examined the 
difference between baseline and one, six and twelve months for each pair of intervention 
groups.  We used  robust  generalized  estimating  equations  (Zeger  and  Liang,  1986)  with 
unstructured correlation structure using a logit link and binomial distribution for the outcomes. 
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This method takes account of the correlation between repeated observations from the same 
individual. To examine the intervention effect, we tested the interaction between intervention 
group and time in each model, and presented odds ratios (OR) with 95% confidence intervals 
(CI).  We also  analysed  the  data  adjusting  for  stratification  variables,  relationship  status, 
education, ethnicity and Index of Multiple Deprivation, fitting categorical variables as binary 
variables and Index of Multiple Deprivation on a continuous scale (0 to 100). We calculated the 
intracluster  correlation  coefficient  for  radiographer  and  centre  using  one-way  analysis  of 
variance, adjusting for unequal cluster size (Fleiss, 1981; Armitage and Berry,1994).
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RESULTS
Flow of participants 
Between August 2007 and May 2008, we randomised 867 women to one of three arms: usual 
care (n=287), the booklet in addition to usual care (n=294), and the interaction supported by the 
booklet in addition to usual care (n=286) (Figure 1). Only 15% (176/1209) of women who were 
assessed for eligibility chose not to participate. Eleven women did not receive the allocated 
intervention and 25 were lost to follow-up (20 withdrew consent, three moved with no forwarding 
address, one for medical reasons and one died). We included women with data for the primary 
outcome on at least one occasion in the main analysis (n=851). We were unable to measure any 
outcomes for  four  women who did not  complete any questionnaires (two booklet  arm,  two 
interaction  arm).  We received  breast  cancer  awareness questionnaires  from 89% of  those 
randomised at one month and 83% at one year; response rates were similar in each arm (Figure 
1).
 
Baseline socio-demographic characteristics
Socio-demographic characteristics were well balanced across the arms (Table 1), except for a 
slight difference in the proportion of women with no educational qualifications (35% usual care, 
41% booklet and 44% interaction arm). Women in the booklet arm had a similar deprivation 
score to the English median, but women in the usual care and interaction plus booklet arms 
lived in somewhat more deprived areas. For women invited for screening but not recruited, the 
only characteristic we had data on was postcode (and, therefore, rank of Index of Multiple 
Deprivation).  The median rank for the 1078 women not recruited was 9,068 (interquartile 
range (IQR): 4,784 to 15,802) compared to 15,664 (IQR: 8,589 to 25,989) for the 867 women 
in the trial, so women who did not take part lived in more deprived areas than those who did.
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Breast cancer awareness 
Table 2 shows the main results for breast cancer awareness score and its components for 
baseline, one month and one year (six month data are not presented). Figure 2 illustrates 
breast cancer awareness and components of the score over the twelve month period. Overall, 
only 2.7% of women were breast cancer aware at baseline. At one month, the interaction plus 
booklet increased the proportion who were breast cancer aware compared with usual care 
(32.8% versus 4.1%; OR 24.0, 95% CI 7.7 to 73.7), as did the booklet, although the effect of 
the booklet was much less striking (12.7% versus 4.1%; OR 4.4, 95% CI 1.6 to 12.0). At one 
year,  the  effect  of  the  interaction  plus  booklet,  and the booklet  alone,  on breast  cancer 
awareness remained significant, with the interaction plus booklet remaining more effective. 
The results of the adjusted analysis were similar, although estimated differences between 
arms were mostly slightly larger (data not shown). 
Knowledge of breast cancer symptoms
Forty two percent of women were able to identify five or more non-lump symptoms at baseline. 
At one month, the interaction plus booklet increased the proportion of women able to identify 
five or more non-lump symptoms compared with usual care (78.9% versus 54.2%; difference 
24.7%; OR 2.5,  95% CI 1.7 to 3.6) but  the booklet alone did not  (61.6% versus 54.2%; 
difference  7.4%;  OR 1.1,  95% CI  0.8  to  1.5).  The  increase  in  knowledge of  symptoms 
associated with the interaction plus booklet was maintained at one year. Before receiving the 
intervention, the women were able to identify a median of four non-lump symptoms from the 
list of nine (IQR: 2 to 6), and most recognised a lump in the breast or armpit as symptoms. At 
one year, this increased to a median of six symptoms (IQR: 4 to 9) among those receiving the 
booklet only, and to seven (IQR: 4 to 9) among those receiving the interaction plus booklet. 
The intervention had most impact on the two least recognised symptoms; redness of skin and 
nipple rash (Figure 3).
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Knowledge of age-related risk
Only 11.4% of the women knew that a 70 year old woman was most at risk of breast cancer at 
baseline. At one month, the interaction plus booklet increased the proportion knowing that a 70 
year old was at most risk of breast cancer compared with usual care (44.7% versus 8.7%; 
difference 36.0%: OR 9.5, 95% CI 5.1 to 17.6), as did the booklet alone (24.9% versus 8.7%; 
difference 16.2%; OR 3.2, 95% CI 1.8 to 5.8). At one year, the effect of the interaction plus 
booklet and the booklet alone remained significant.
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Breast checking
About half of the women reported checking their breasts at least once a month at baseline. At 
one month, the interaction plus booklet increased the proportion of women checking their 
breasts at least monthly compared with usual care (77.7% versus 62.5%; difference 15.2%; 
OR 2.0, 95% CI 1.4 to 2.8), but the booklet alone did not (61.3% versus 62.5%; difference 
-1.2%; OR 1.2, 95% CI 0.9 to 1.6). The effect of the interaction plus booklet was no longer 
significant at one year. 
Intervention delivery
A total of 279 interactions were conducted and 82% were video-recorded and assessed by an 
independent rater (38 were not usable due to technical faults; five were incomplete; four were 
audio-taped  only;  two  women  refused  recording,  and  one  tape  was  lost).  Quality  of 
intervention delivery was high: median content score was 96 (range: 68 to 100) (only five 
interactions (2%) scored less than 80); median style score was 85 (range: 37 to 100) (79 
interactions (35%) scored less than 80). One per cent of the total variability in the breast 
cancer awareness score at one month was attributable to radiographer, and 0.6% to centre. 
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DISCUSSION
The intervention increased breast cancer awareness amongst older women compared with 
usual care at one month, with the interaction supplemented by a booklet having a greater 
effect than the booklet alone.  Thirty three per cent of those receiving the interaction plus 
booklet and 13% of those receiving the booklet alone were breast cancer aware compared 
with 4% of women receiving usual care. These improvements in breast cancer awareness 
were sustained at twelve months although were somewhat less marked (24% of the interaction 
plus booklet group and 12% of the booklet only group compared with 4% of the usual care 
group). Of the three components of breast cancer awareness, the interaction plus booklet and 
the  booklet  alone  had  the  most  marked  effect  on  knowledge  of  age-related  risk.  The 
interaction  plus  booklet  was  also  associated  with  a  statistically  significant  increase  in 
knowledge of breast cancer symptoms. 
Only 3% of the women were breast cancer aware (as defined prospectively for this study) at 
baseline.  This  may  explain  why  so  many  women  delay  presenting  with  breast  cancer 
symptoms and have poor survival as a result. Knowledge of age-related risk was particularly 
poor (only 11% were aware that a 70 year old woman was at higher risk than a 30 year old or 
a 50 year old), perhaps because of heavy media coverage of younger women with breast 
cancer and the current upper age limits on the NHS Breast Screening Programme.
The efficacy of the booklet alone was limited. It was important to test the booklet alone as it 
would be cheaper to deliver on the NHS than the one-to-one interaction. The interaction plus 
booklet  was probably more effective because it  incorporated features thought to  promote 
behaviour  change:  a  direct  recommendation  from  a  health  professional  (Jepson,  2000); 
tailoring (Jepson, 2000); and positive motivational style and verbal persuasion (Wardle et al, 
2003; Rollnick and Miller, 1995).
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Knowledge of non-lump symptoms and reported breast checking increased quite markedly in 
the women who received usual care alone over the twelve month follow-up. This may be due 
to  what  has  been  called  the  “mere  measurement”  effect  (Godin  et  al,  2008):  either  the 
questionnaire itself  increased awareness, or women started to guess the correct,  or most 
appropriate, answers because repeatedly asked the same question. 
A systematic review of interventions to promote cancer awareness found very limited evidence 
of  effectiveness  of  any  interventions.  It  found  only  five  randomised  controlled  trials  of 
interventions to promote cancer awareness aimed at individuals, of moderate to good quality 
(Austoker et al, 2009 this supplement). All found more modest effects on cancer awareness 
than we achieved. The trial finding the greatest effect was of an intensive intervention (tailored 
written information with a reinforcing newsletter at 12 months plus two telephone counselling 
sessions) primarily aiming to increase breast screening uptake. It increased the proportion 
who gave the correct answer to a question about age-related risk by 12% compared with usual 
care after two years  (Rimer  et al,  2002). In our study, the interaction plus booklet,  which 
increased the proportion correctly identifying a 70 year old as at higher risk than a 50 year old 
or 30 year old by 27% at twelve months, compares well with this. Less intensive interventions 
such as mailed information (de Nooijer  et al,  2004) and interactive computer programmes 
(Glazebrook  et  al,  2006) increased cancer awareness more modestly. The effects  of  the 
interaction plus booklet on reported breast checking at least monthly (77% versus 72% after 
twelve  months) are similar  to  those found in  trials  to  promote breast  self-examination:  a 
randomised controlled trial in the United States found that a 45-minute class increased the 
proportion who reported monthly breast self-examination from 51% to 62% after six months 
(Strickland et al, 1997).
Our  intervention  is  not  a  tutorial  in  breast  self-examination.  The  evidence  to  support 
systematic, regular breast self-examination is weak: a Cochrane systematic review found that 
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breast self examination did not reduce mortality and increased investigations (Kosters and 
Gotzsche, 2003). However, both trials included in the review recruited women under the age of 
67; whether breast checking, or even breast self examination, would increase detection rates 
and reduce mortality in older women is unknown. What seems highly unlikely is that women 
who never look at or touch their breasts (20% of older women (Linsell et al, 2008)) will detect 
symptoms early; our intervention is designed to encourage simply looking and touching.
Strengths  of  our  trial  were  the  high  level  of  participation  (84% of  eligible  women were 
randomised) and the high response to follow up (83% at twelve months). The usual care arm 
had slightly higher levels of education than the interaction arm; however, adjusting for baseline 
characteristics did not significantly change the size of the estimates.
The NHS Breast Screening Programme is an efficient setting for recruiting large numbers of 
healthy older women: uptake of breast screening in women aged 65 to 70 is over 70% (NHS 
Breast  Screening Programme,  2009).  Women who take  up breast  screening live  in  less 
deprived areas than those who do not (Banks et al, 2002; Maheswaran et al, 2006), although 
the women in our study lived in slightly more deprived areas than the English average. Should 
the intervention be implemented across more affluent  populations,  it  is  likely that  women 
receiving it would be of higher socioeconomic status than those not receiving it.  However, 
these women are at higher risk of breast cancer (Threlfall and Woodman, 2001; Shack et al, 
2008) so it is appropriate to target them in this setting. 
We developed a score for measuring breast cancer awareness to be used in surveys and 
trials.  Currently,  there  is  no  universally  accepted  measure  of  breast  cancer  awareness 
(although the breast cancer module of the Cancer Awareness Measure is being developed) 
and no published agreement on what the concept means. We argue that it  is not a single 
construct, so, in developing our measure, we included three constructs that we felt encompass 
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the  minimum  information  women  need  to  be  able  present  promptly  with  breast  cancer 
symptoms: why to look for them (magnitude of risk), what to look for (the range of symptoms), 
and how to look for them (to look at and feel their breasts). 
Health professional-delivered complex interventions such as ours are prone to variability in the 
quality  of  delivery  because  they  are  made  up  of  many  components  and  are  operator-
dependent,  and  this  may influence  whether  they  work  or  not.  In  psychotherapy  trials,  a 
significant amount of the variability in participant outcome has been shown to be attributable to 
variable delivery by different therapists  (Crits-Christoph  et al,  1991; Wampold and Brown, 
2005; Okiishi  et al,  2003). In our trial, we found no evidence of important variation in the 
quality of delivery of the interaction between those delivering it. 
We  recognise  that  some  of  the  symptoms  included  in  the  intervention  and  the 
questionnaire (for example, lump in armpit) are likely to indicate disease of a worse 
prognosis. We included these symptoms because even in women with more advanced 
disease than stage I, earlier detection may improve prognosis. In addition, we felt it 
important to include all symptoms of breast cancer in the list as their absence might 
give a misleading message.  
It  could be argued that inviting older women for screening on the NHS Breast Screening 
Programme might be a better way of promoting earlier diagnosis in breast cancer (currently 
the upper age limit for routine invitation is 70; this is soon to increase to 73). However, breast 
screening is expensive and the cost-effectiveness of inviting older women for screening is not 
clear. Raising awareness is likely to compare favourably in cost-effectiveness terms, and may 
have a more prolonged effect than a further round of screening. In addition, research in the 
UK has consistently shown low public awareness of the early warning signs of breast cancer 
(Moser  et  al,  2007;  Grunfeld  et  al,  2002;  Adlard  and Hume,  2003;  Wardle  et  al,  2001; 
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Brunswick et al, 2001) particularly among older women (Linsell et al, 2008). This is thought to 
be more likely  to  explain  survival  differences between the UK and  other  countries  than 
differences in availability or uptake of breast screening (Richards, 2009 this supplement). 
Another reason to evaluate interventions to promote breast cancer awareness is that it may 
have implications for increasing cancer awareness and survival in other cancers, for which 
screening programmes may not be available.
We have shown that our intervention, a ten-minute interaction with a health professional plus a 
booklet, promotes breast cancer awareness in older women after twelve months. This trial was 
not designed to show whether it will promote early presentation in breast cancer and thereby 
improve survival, although we do plan to evaluate the effect on screening uptake three years 
after randomisation. There is an established association between delayed presentation and 
survival  (Richards  et  al,  1999),  but  the  evidence  linking  cancer  awareness  and  early 
presentation is less strong. There is evidence that poor knowledge of non-lump symptoms is 
associated with delay in presentation (Ramirez et al, 1999). Other evidence is indirect: women 
belonging to populations most likely to have delayed diagnosis of breast cancer (Ramirez et al, 
1999),  also  have  lower  cancer  awareness,  including  older  women,  women  of  lower 
socioeconomic status and black women (Grunfeld et al, 2002; Linsell et al, 2008; Scanlon and 
Wood, 2005). We acknowledge that this trial does not provide evidence that our intervention 
will  promote early presentation, although that is its ultimate aim.  We plan further trials to 
examine whether  the  intervention reduces delay in  presentation,  but  these,  much larger, 
studies would not be possible without first building the evidence for its effect on breast cancer 
awareness, which we hypothesise is on the causal pathway.
Delay in presentation in breast cancer is an important public health problem. We estimate that 
7,000 to 12,000 women delay presentation for more than three months in England each year 
(Richards et al, 1999; Office for National Statistics, 2008). Women who delay presenting for 
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three to six months have 7% lower five year survival than those with shorter delays (Richards 
et al, 1999). If only 7000 women per year in England delay presentation for more than three 
months, about 500 will die as a result (assuming a five year breast cancer survival of 80% in 
women who delay less than three months and 73% in those who delay more than three 
months). If we find that the intervention reduces breast cancer mortality, it could be one of the 
key elements of a programme to bring UK breast cancer survival closer to the standards 
obtained in similar countries. It may also deliver other benefits, to women themselves and the 
NHS, as a result of less intensive breast cancer treatment given at an earlier stage.
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Figure 1: Flow of participants through trial
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Table 1. Baseline characteristics of participants
Usual care
(n=287)
Booklet
(n=292)
Interaction plus 
booklet
(n=284)
Relationship status, n (%) (n=285) (n=283) (n=282)
    Married or cohabiting
    Widowed
    Single
    Divorced or separated
162
56
22
45
(56.8)
(19.7)
(7.7)
(15.8)
151
61
28
43
(53.4)
(21.6)
(9.9)
(15.2)
174
50
17
41
(61.7)
(17.7)
(6.0)
(14.5)
Education, n (%) (n=266) (n=269) (n=263)
    No formal qualifications
    O level or school certificate
    A level or Higher school certificate
    Degree or above
93
89
34
50
(35.0)
(33.5)
(12.8)
(18.8)
109
81
31
48
(40.5)
(30.1)
(11.5)
(17.8)
116
77
29
41
(44.1)
(29.3)
(11.0)
(15.6)
Ethnic group, n (%) (n=281) (n=284) (n=280)
    White British
    White other
    Black-Caribbean
    Other 
187
23
36
35
(66.6)
(8.2)
(12.8)
(12.5)
196
23
38
27
(69.0)
(8.1)
(13.4)
(9.5)
186
32
37
25
(66.4)
(11.4)
(13.2)
(8.9)
Index of Multiple Deprivation, 
median rank (IQR) (n=286) (n=293) (n=286)
   (1 (most) to 32,482 (least) deprived) 14,557
(8,222 to 25,989)
16,511
(8,809 to 26,184)
15,375
(8,575 to 25,729)
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Table 2. Breast cancer awareness and component items at one month and one year post-randomisation
Baseline One month One year
Usual 
care
Booklet Interaction 
plus booklet
Usual 
care
Booklet Interaction 
plus booklet
Usual 
care
Booklet Interaction 
plus booklet
Breast cancer awareness
Number (%) breast cancer aware*
9/267 8/275 5/272 10/244 30/237 75/229 9/229 26/227 53/225
(3.4) (2.9) (1.8) (4.1) (12.7) (32.8) (3.9) (11.5) (23.6)
Odds ratio (95% CI), p value  
(versus usual care)
1.0 4.4
(1.6 to 12.0)
p=0.004
24.0 
(7.7 to 73.7)
p<0.001
1.0 3.5 
(1.2 to 10.5)
p=0.025
15.2
(4.8 to 47.8)
p<0.001
Knowledge of breast cancer 
symptoms 
Number (%) identifying more than 
five non-lump symptoms
111/284 126/286 122/280 136/251 151/245 187/237 142/233 167/236 170/230
(39.1) (44.1) (43.6) (54.2) (61.6) (78.9) (60.9) (70.8) (73.9)
Odds ratio (95% CI), p value 
(versus usual care)
1.0 1.1 
(0.8 to 1.5)
p=0.61
2.5 
(1.7 to 3.6)
p<0.001
1.0 1.3 
(0.9 to 1.9)
p=0.23
1.7 
(1.1 to 2.4)
p=0.01
Knowledge of age-related risk 
Number (%) identifying a 70 year old 
woman as most likely to get breast 
cancer
30/269 36/282 28/276 22/254 62/249 109/244 16/234 53/237 78/234
(11.2) (12.8) (10.1) (8.7) (24.9) (44.7) (6.8) (22.4) (33.3)
Odds ratio (95% CI), p value 
(versus usual care)
1.0 3.2 
(1.8 to 5.8)
p<0.001
9.5 
(5.1 to 17.6)
p<0.001
1.0 3.4 
(1.8 to 6.7)
p<0.001
7.4 
(3.7 to 14.7)
p<0.001
Breast checking
Number (%) reporting breast 
checking at least once a month
152/285 139/288 154/284 163/261 157/256 192/247 171/239 169/243 180/234
(53.3) (48.3) (54.2) (62.5) (61.3) (77.7) (71.6) (70.0) (76.9)
Odds ratio (95% CI), p value 
(versus usual care)
1.0 1.2 
(0.9 to 1.6)
p=0.25
2.0
(1.4 to 2.8)
p<0.001
1.0 1.1 
(0.8 to 1.6)
p=0.47
1.3
(0.9 to 1.8)
p=0.23
* A woman scored three points on the breast cancer awareness score if she: identified at least five non-lump symptoms (one point); identified that a 70 year old woman is most at risk of breast cancer 
(one point), and reported checking her breasts at least once a month (one point).
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Figure 2. Breast cancer awareness and component items at baseline, one month and one year post-randomisation
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* A woman scored three points on the breast cancer awareness score if she: identified at least five non-lump symptoms (one point); identified that a 70 year old woman is 
most at risk of breast cancer (one point), and reported checking her breasts at least once a month (one point).
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Figure 3. Proportions of women identifying symptoms of breast cancer 
at baseline, one month and one year post-randomisation
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